These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 10559324)
1. Induction of transformation and p53-dependent apoptosis by adenovirus type 5 E4orf6/7 cDNA. Yamano S; Tokino T; Yasuda M; Kaneuchi M; Takahashi M; Niitsu Y; Fujinaga K; Yamashita T J Virol; 1999 Dec; 73(12):10095-103. PubMed ID: 10559324 [TBL] [Abstract][Full Text] [Related]
2. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein. Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196 [TBL] [Abstract][Full Text] [Related]
3. E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter. Pützer BM; Rumpf H; Rega S; Brockmann D; Esche H J Virol; 1997 Dec; 71(12):9538-48. PubMed ID: 9371617 [TBL] [Abstract][Full Text] [Related]
4. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53. Nevels M; Spruss T; Wolf H; Dobner T Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915 [TBL] [Abstract][Full Text] [Related]
5. The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex. Obert S; O'Connor RJ; Schmid S; Hearing P Mol Cell Biol; 1994 Feb; 14(2):1333-46. PubMed ID: 8289811 [TBL] [Abstract][Full Text] [Related]
6. Induction of the cellular E2F-1 promoter by the adenovirus E4-6/7 protein. Schaley J; O'Connor RJ; Taylor LJ; Bar-Sagi D; Hearing P J Virol; 2000 Mar; 74(5):2084-93. PubMed ID: 10666238 [TBL] [Abstract][Full Text] [Related]
7. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Nevins JR Science; 1992 Oct; 258(5081):424-9. PubMed ID: 1411535 [TBL] [Abstract][Full Text] [Related]
8. Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein. Nevels M; Rubenwolf S; Spruss T; Wolf H; Dobner T J Virol; 2000 Jun; 74(11):5168-81. PubMed ID: 10799592 [TBL] [Abstract][Full Text] [Related]
9. A cellular repressor of E1A-stimulated genes that inhibits activation by E2F. Veal E; Eisenstein M; Tseng ZH; Gill G Mol Cell Biol; 1998 Sep; 18(9):5032-41. PubMed ID: 9710587 [TBL] [Abstract][Full Text] [Related]
10. Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome. Swaminathan S; Thimmapaya B J Mol Biol; 1996 May; 258(5):736-46. PubMed ID: 8637006 [TBL] [Abstract][Full Text] [Related]
11. Transforming potential of the adenovirus type 5 E4orf3 protein. Nevels M; Täuber B; Kremmer E; Spruss T; Wolf H; Dobner T J Virol; 1999 Feb; 73(2):1591-600. PubMed ID: 9882365 [TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein. Arroyo M; Raychaudhuri P Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728 [TBL] [Abstract][Full Text] [Related]
13. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity. Wong HK; Ziff EB J Virol; 1996 Jan; 70(1):332-40. PubMed ID: 8523545 [TBL] [Abstract][Full Text] [Related]
14. Oncogenic potential of the adenovirus E4orf6 protein. Moore M; Horikoshi N; Shenk T Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11295-301. PubMed ID: 8876129 [TBL] [Abstract][Full Text] [Related]
15. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Hiebert SW Mol Cell Biol; 1993 Jun; 13(6):3384-91. PubMed ID: 8497257 [TBL] [Abstract][Full Text] [Related]
16. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation. Kirch HC; Pützer B; Schwabe G; Gnauck HK; Schulte Holthausen H Cell Mol Biol Res; 1993; 39(8):705-16. PubMed ID: 7951410 [TBL] [Abstract][Full Text] [Related]
17. Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein. Helin K; Harlow E J Virol; 1994 Aug; 68(8):5027-35. PubMed ID: 8035503 [TBL] [Abstract][Full Text] [Related]
18. Rb may act as a transcriptional co-activator in undifferentiated F9 cells. Bocco JL; Reimund B; Chatton B; Kedinger C Oncogene; 1993 Nov; 8(11):2977-86. PubMed ID: 8414500 [TBL] [Abstract][Full Text] [Related]
19. The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis. Marcellus RC; Lavoie JN; Boivin D; Shore GC; Ketner G; Branton PE J Virol; 1998 Sep; 72(9):7144-53. PubMed ID: 9696808 [TBL] [Abstract][Full Text] [Related]
20. The Human Adenovirus Type 5 E4orf6/E1B55K E3 Ubiquitin Ligase Complex Enhances E1A Functional Activity. Dallaire F; Schreiner S; Blair GE; Dobner T; Branton PE; Blanchette P mSphere; 2016; 1(1):. PubMed ID: 27303687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]